newsfilter
← Latest News
GlobeNewswire·

Pasithea Therapeutics Announces Closing of $5 Million Public Offering

MIAMI, May 07, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. ("Pasithea," or the "Company") (NASDAQ:KTTA, KTTAW)), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK